Affiliation：

2024-  Pfizer / Health Representative  輝瑞藥廠業務代表

Degree：

2022 The M.S. of Medical Science and Technology, NSYSU, Taiwan

Thesis：利用雙靶向奈米反應器針對三陰性乳癌進行化學動力治療以及免疫治療 Dual-targeted nanoreactor for the combination of chemodynamic therapy and immunotherapy in triple-negative breast cancer 

Publication：

Y.T. Chen, Y.X. Luo, S.H. Chan, W.Y. Chiu*, H.W. Yang*. Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer. Journal of Nanobiotechnology 21, 385 (2023). (IF = 12.6)